Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
There’s a New Emperor in Town: Marcus-Aurelius Empowers SMBs to Achieve Digital Success with Expert Website Design and Strategic Consulting
-
Current Water Announces First Quarter 2024 Financial Results
-
Mark Cuban Foundation and Notified Bring AI Bootcamp to Portland Teens
-
Mark Cuban Foundation and Headstorm Bring AI Bootcamp to Addison Teens
-
SME Launches Search for Next CEO
-
Fundamental Global Inc. and Strong Global Entertainment, Inc. Enter Into Definitive Plan of Arrangement
-
Mark Cuban Foundation and Miami Dade College Bring AI Bootcamp to Miami Teens
-
Alliance Trust PLC - Net Asset Value
-
Mark Cuban Foundation and Corteva Bring AI Bootcamp to Indianapolis Teens
-
KSCA Cannabis Virtual Investor Conference Agenda Announced for June 5th
-
Form 8.3 - Keywords Studios plc
-
Torr Metals Inc. (TSX.V: TMET) Featured in Syndicated Broadcast Covering Significant Increase in Sizing of Kolos Copper-Gold Project
-
Data and Safety Monitoring Board Approves Simultaneous Enrollment in Cohort 3 and Phase 2 Initiation in OCU410 ArMaDa study for Geographic Atrophy
-
Form 8.3 - Mattioli Woods plc
-
SNDL to Present at the KCSA Cannabis Virtual Investor Conference June 5th
-
Glass House Brands to Present at the KCSA Cannabis Virtual Investor Conference June 5th
-
Interim Report for the period January 1 – March 31, 2024
-
The Real Good Food Company Receives Nasdaq Notice Regarding Filing Requirements
-
Global Water Resources Declares Monthly Dividend
-
EMCORE's Chief Scientist Sergey Zotov to Present a Talk on the Journey from Tactical to High-End Navigation-Grade MEMS Accelerometers at the Joint Navigation Conference
-
Victory Square Technologies Reports Q1 2024 Financial Results
-
Sharps Technology’s SC Asset Purchase and $200 Million Syringe Sales Agreement Paves the Way to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.
-
Mullen Announces Hiring of Former European Manheim and Copart Executive, Alain Van Munster, to Lead Europe Sales Efforts
-
AIM ImmunoTech Announces Pricing of $2.0 Million Registered Direct Offering
-
La Rosa to Present at the Spring MicroCap Rodeo Conference on June 6th
-
SRIVARU (SVMH) to Present at the Spring MicroCap Rodeo Conference on June 6th
-
Inuvo CEO to Participate in Fireside Chat at the Maxim Group TMT Conference on June 5, 2024
-
Jet.AI to Present at the Maxim Group Virtual TMT Conference on Tuesday, June 4, 2024
-
HealthPRO Canada Delivers Tangible Sustainability Strategies to Empower Healthcare Organizations
-
Vow ASA: Breakthrough contract confirmed in cruise
-
Form 8.3 - Lok’n Store Group PLC
-
Form 8.3 - Balanced Commercial Property Trust Limited
-
Autonomix Medical, Inc. Reports Full Year 2024 Financial Results and Provides Corporate Update
-
Twin Disc, Inc. Completes Acquisition of Katsa Oy
-
Haoxi Health Technology Limited Reports Unaudited Financial Results for The Six Months Ended December 31, 2023
-
Generation Lab Introduces First Platform that Measures Aging & Treatment Efficacy to Help Extend the Human Healthspan
-
Rogers starts to expand 5G network to rest of TTC subway system
-
Solar Alliance reports profitable Q1 result supported by 70% year-over-year revenue increase
-
PrairieSky Receives TSX Approval for Renewed Normal Course Issuer Bid
-
Total Energy Services Inc. Announces Dividend
-
SS Innovations Engages BDO as its new Auditor
-
Aptose Announces $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
Bionomics Limited Announces Private Placement of up to $70.0 Million
-
eGain Announces Increase to Stock Repurchase Program of $20 Million
-
ABM Named Among Barron’s 100 Most Sustainable Companies for Second Consecutive Year
-
Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus
-
Milestone® Pharmaceuticals to Participate in the Upcoming Jefferies Global Healthcare Conference
-
Morphic to Participate in Jefferies Global Healthcare Conference
-
Bitdeer Announces Up to $150 Million Private Placement Financing
-
Autolus Therapeutics presents longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL in an oral presentation at ASCO
